Financhill
Back

Allakos Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
6

ALLK
Allakos

Last Price:
0.54
Seasonality Move:
25.88%
Sell
29

NBY
NovaBay Pharmaceuticals

Last Price:
0.51
Seasonality Move:
-14.79%
Sell
6
Allakos (ALLK) is a Sell

Is Allakos a Buy, Sell or Hold?

  • The current Allakos [ALLK] share price is $0.56. The Score for ALLK is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • ALLK is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALLK Stock Price Chart

What is Allakos's stock price today?

  • The Allakos share price today is $0.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLK is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 35.37 Sell
Chaikin Money Flow: -152228 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.73) Sell
Bollinger Bands (100): (0.71 - 1.21) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 40.27 Sell
Chaikin Money Flow: 161961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Buy
Bollinger Bands (100): (0.64 - 3.4) Sell

ALLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.6 Sell
20-day SMA: 0.67 Sell
50-day SMA: 0.74 Sell
200-day SMA: 1.35 Sell
8-day EMA: 0.6 Sell
20-day EMA: 0.65 Sell
50-day EMA: 0.76 Sell
200-day EMA: 1.51 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.48 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.93 Sell
200-day SMA: 3.89 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.99 Sell
200-day EMA: 8.5 Sell

Allakos Earnings Growth & ALLK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.04 per share, an increase this year of $0.38 per share, and an increase next year of $0.85 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Allakos Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):